首页> 外文期刊>Biotechnology and Applied Biochemistry >Selection and characterization of novel DNA aptamer against colorectal carcinoma Caco-2 cells
【24h】

Selection and characterization of novel DNA aptamer against colorectal carcinoma Caco-2 cells

机译:抗结肠直肠癌Caco-2细胞新型DNA适体的选择与表征

获取原文
获取原文并翻译 | 示例
           

摘要

Aptamers are short, single-stranded nucleic acid (DNA or RNA) oligonucleotides that can be obtained by a technique called systematic evolution of ligands by exponential enrichment (SELEX) in vitro. Due to superior properties such as small size, high binding affinity, and stability, they are considered to be feasible tools for diagnosis and treatment of disease. In the current study, we attempted to screen a high-affinity DNA aptamer to selectively target the colorectal carcinoma Caco-2 cells by using cell-based SELEX approach. After 14 consecutive rounds of selection, aptamer ApC1 was identified. Confocal microscopy results revealed that ApC1 could rapidly internalize into Caco-2 cells but not HEK 293 cells. Moreover, it showed high specificity to Caco-2 cells rather than other cell lines such as 293T, HeLa, MCF-7, HL-60, and NB4. Collectively, our results demonstrated that aptamer ApC1 has high specificity to colorectal carcinoma Caco-2 cells, which could be further applied for targeted therapy of colorectal cancer in future studies.
机译:适体是短,单链核酸(DNA或RNA)寡核苷酸,其可通过幂富集(SELEX)在体外称为配体的系统演化的技术。由于尺寸小,粘合亲和力和稳定性等优异的性质,它们被认为是可行的诊断和治疗疾病的工具。在目前的研究中,我们试图通过使用基于细胞的SELEX方法筛选高亲和力DNA适体以选择性地靶向结肠直肠癌Caco-2细胞。在连续14轮选择之后,确定了Aptamer APC1。共聚焦显微镜结果表明,APC1可以迅速内化到Caco-2细胞中,而不是HEK 293细胞。此外,它显示出CaCO-2细胞的高特异性,而不是其他细胞系,例如293T,Hela,MCF-7,HL-60和NB4。统称,我们的结果表明,适体APC1对结直肠癌Caco-2细胞具有高特异性,这可以进一步应用于未来研究中的结肠直肠癌的靶向治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号